Received Dec 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Z008197 | — |
No side effects or symptoms reported. No Additional AE; HCP called to report TE where patient received product after it was improperly stored.; This spontaneous report was received from a medical assistant referring to a 4-year-old male patient. The patient's medical history, historical drugs, past drug adverse reactions or allergies, concurrent conditions, or concomitant drugs were not reported. On 03-NOV-2025, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) injection (0.5 ml, lot#: z008197, expiration date: 30-APR-2027; route of administration was not reported) administered by a health professional for prophylaxis after it was improperly stored at -10.5C for 1 hour (product storage error). No previous excursions occurred. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot#, and expiration date were not reported). No side effects or symptoms reported. No additional adverse events (AE) were reported (no adverse event). Lot# is being requested and will be submitted if received.
MERCK STERILE DILUENT